BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 20156804)

  • 21. A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor.
    Trofatter JA; MacCollin MM; Rutter JL; Murrell JR; Duyao MP; Parry DM; Eldridge R; Kley N; Menon AG; Pulaski K
    Cell; 1993 Mar; 72(5):791-800. PubMed ID: 8453669
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The neurofibromatosis 2 (NF2) tumour suppressor gene: implications beyond the hereditary tumour syndrome?
    Kley N; Seizinger BR
    Cancer Surv; 1995; 25():207-18. PubMed ID: 8718520
    [TBL] [Abstract][Full Text] [Related]  

  • 23. NF2: the wizardry of merlin.
    Xiao GH; Chernoff J; Testa JR
    Genes Chromosomes Cancer; 2003 Dec; 38(4):389-99. PubMed ID: 14566860
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Moesin-ezrin-radixin-like protein (merlin) mediates protein interacting with the carboxyl terminus-1 (PICT-1)-induced growth inhibition of glioblastoma cells in the nucleus.
    Chen H; Mei L; Zhou L; Zhang X; Guo C; Li J; Wang H; Zhu Y; Zheng Y; Huang L
    Int J Biochem Cell Biol; 2011 Apr; 43(4):545-55. PubMed ID: 21167305
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mutant products of the NF2 tumor suppressor gene are degraded by the ubiquitin-proteasome pathway.
    Gautreau A; Manent J; Fievet B; Louvard D; Giovannini M; Arpin M
    J Biol Chem; 2002 Aug; 277(35):31279-82. PubMed ID: 12130630
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The neurofibromatosis type 2 gene product, merlin, reverses the F-actin cytoskeletal defects in primary human Schwannoma cells.
    Bashour AM; Meng JJ; Ip W; MacCollin M; Ratner N
    Mol Cell Biol; 2002 Feb; 22(4):1150-7. PubMed ID: 11809806
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Localization to the cortical cytoskeleton is necessary for Nf2/merlin-dependent epidermal growth factor receptor silencing.
    Cole BK; Curto M; Chan AW; McClatchey AI
    Mol Cell Biol; 2008 Feb; 28(4):1274-84. PubMed ID: 18086884
    [TBL] [Abstract][Full Text] [Related]  

  • 28. NF2/merlin is a novel negative regulator of mTOR complex 1, and activation of mTORC1 is associated with meningioma and schwannoma growth.
    James MF; Han S; Polizzano C; Plotkin SR; Manning BD; Stemmer-Rachamimov AO; Gusella JF; Ramesh V
    Mol Cell Biol; 2009 Aug; 29(15):4250-61. PubMed ID: 19451225
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Moesin is a glioma progression marker that induces proliferation and Wnt/β-catenin pathway activation via interaction with CD44.
    Zhu X; Morales FC; Agarwal NK; Dogruluk T; Gagea M; Georgescu MM
    Cancer Res; 2013 Feb; 73(3):1142-55. PubMed ID: 23221384
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification and characterization of putative tumor suppressor NGB, a GTP-binding protein that interacts with the neurofibromatosis 2 protein.
    Lee H; Kim D; Dan HC; Wu EL; Gritsko TM; Cao C; Nicosia SV; Golemis EA; Liu W; Coppola D; Brem SS; Testa JR; Cheng JQ
    Mol Cell Biol; 2007 Mar; 27(6):2103-19. PubMed ID: 17210637
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mice heterozygous for a mutation at the Nf2 tumor suppressor locus develop a range of highly metastatic tumors.
    McClatchey AI; Saotome I; Mercer K; Crowley D; Gusella JF; Bronson RT; Jacks T
    Genes Dev; 1998 Apr; 12(8):1121-33. PubMed ID: 9553042
    [TBL] [Abstract][Full Text] [Related]  

  • 32. NF2/Merlin Inactivation and Potential Therapeutic Targets in Mesothelioma.
    Sato T; Sekido Y
    Int J Mol Sci; 2018 Mar; 19(4):. PubMed ID: 29587439
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Shedding light on Merlin's wizardry.
    Okada T; You L; Giancotti FG
    Trends Cell Biol; 2007 May; 17(5):222-9. PubMed ID: 17442573
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MicroRNA‑92a promotes cell proliferation, migration and survival by directly targeting the tumor suppressor gene NF2 in colorectal and lung cancer cells.
    Alcantara KMM; Garcia RL
    Oncol Rep; 2019 Apr; 41(4):2103-2116. PubMed ID: 30816526
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inherited genetic syndromes and meningiomas.
    Look A; Lonser RR
    Handb Clin Neurol; 2020; 169():121-129. PubMed ID: 32553283
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The expression and phosphorylation of ezrin and merlin in human pancreatic cancer.
    Zhou J; Feng Y; Tao K; Su Z; Yu X; Zheng J; Zhang L; Yang D
    Int J Oncol; 2014 Jun; 44(6):2059-67. PubMed ID: 24728215
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The neurofibromatosis 2 tumor suppressor gene product, merlin, regulates human meningioma cell growth by signaling through YAP.
    Striedinger K; VandenBerg SR; Baia GS; McDermott MW; Gutmann DH; Lal A
    Neoplasia; 2008 Nov; 10(11):1204-12. PubMed ID: 18953429
    [TBL] [Abstract][Full Text] [Related]  

  • 38. NF2-deficient cells depend on the Rac1-canonical Wnt signaling pathway to promote the loss of contact inhibition of proliferation.
    Bosco EE; Nakai Y; Hennigan RF; Ratner N; Zheng Y
    Oncogene; 2010 Apr; 29(17):2540-9. PubMed ID: 20154721
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Merlin/NF2 suppresses tumorigenesis by inhibiting the E3 ubiquitin ligase CRL4(DCAF1) in the nucleus.
    Li W; You L; Cooper J; Schiavon G; Pepe-Caprio A; Zhou L; Ishii R; Giovannini M; Hanemann CO; Long SB; Erdjument-Bromage H; Zhou P; Tempst P; Giancotti FG
    Cell; 2010 Feb; 140(4):477-90. PubMed ID: 20178741
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evidence for a cytoskeleton attachment domain at the N-terminus of the NF2 protein.
    den Bakker MA; Riegman PH; Suurmeijer AP; Vissers CJ; Sainio M; Carpen O; Zwarthoff EC
    J Neurosci Res; 2000 Dec; 62(6):764-71. PubMed ID: 11107160
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.